PA8495001A1 - Nuevas formas cristalinas de un antibiotico macrolido. - Google Patents

Nuevas formas cristalinas de un antibiotico macrolido.

Info

Publication number
PA8495001A1
PA8495001A1 PA20008495001A PA8495001A PA8495001A1 PA 8495001 A1 PA8495001 A1 PA 8495001A1 PA 20008495001 A PA20008495001 A PA 20008495001A PA 8495001 A PA8495001 A PA 8495001A PA 8495001 A1 PA8495001 A1 PA 8495001A1
Authority
PA
Panama
Prior art keywords
macrolido
antibiotic
crystal forms
new crystal
forms
Prior art date
Application number
PA20008495001A
Other languages
English (en)
Inventor
Robert John Rafka
Douglas John Meldrum Allen
Colman Brendan Ragan
Barry James Morton
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8495001A1 publication Critical patent/PA8495001A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE DESCRIBEN NUEVAS FORMAS CRISTALINAS DE UN COMPUESTO DE FORMULA (I) TAMBIEN SE DESCRIBEN COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN ESTAS FORMAS Y PROCEDIMIENTOS PARA SU PREPARACION Y USO.
PA20008495001A 1999-05-18 2000-05-05 Nuevas formas cristalinas de un antibiotico macrolido. PA8495001A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13464499P 1999-05-18 1999-05-18

Publications (1)

Publication Number Publication Date
PA8495001A1 true PA8495001A1 (es) 2002-02-21

Family

ID=22464300

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20008495001A PA8495001A1 (es) 1999-05-18 2000-05-05 Nuevas formas cristalinas de un antibiotico macrolido.

Country Status (43)

Country Link
US (1) US6583274B1 (es)
EP (1) EP1189912B1 (es)
JP (1) JP3897983B2 (es)
KR (1) KR100474229B1 (es)
CN (1) CN1203084C (es)
AP (1) AP2001002325A0 (es)
AR (1) AR020030A1 (es)
AT (1) ATE392427T1 (es)
AU (1) AU772283B2 (es)
BG (1) BG106150A (es)
BR (1) BR0011300A (es)
CA (1) CA2372206C (es)
CZ (1) CZ20014120A3 (es)
DE (1) DE60038610T2 (es)
DK (1) DK1189912T3 (es)
DZ (1) DZ3043A1 (es)
EA (1) EA003417B1 (es)
ES (1) ES2302689T3 (es)
GT (1) GT200000072A (es)
HK (1) HK1045521B (es)
HN (1) HN2000000056A (es)
HR (1) HRP20010849A2 (es)
HU (1) HUP0201341A3 (es)
IL (2) IL145946A0 (es)
IS (1) IS6127A (es)
MA (1) MA26735A1 (es)
MX (1) MXPA01011914A (es)
MY (1) MY133397A (es)
NO (1) NO320195B1 (es)
NZ (1) NZ514765A (es)
OA (1) OA11876A (es)
PA (1) PA8495001A1 (es)
PE (1) PE20010151A1 (es)
PL (1) PL353316A1 (es)
PT (1) PT1189912E (es)
SK (1) SK16472001A3 (es)
TN (1) TNSN00103A1 (es)
TW (1) TWI225066B (es)
UA (1) UA67842C2 (es)
UY (1) UY26144A1 (es)
WO (1) WO2000069874A1 (es)
YU (1) YU76601A (es)
ZA (1) ZA200109420B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
BRPI0017013B1 (pt) 2000-01-27 2015-07-14 Zoetis P Llc Composição de antibiótico azalídeo e método para sua obtenção
WO2002088158A1 (en) * 2001-04-27 2002-11-07 Pfizer Products Inc. Process for preparing 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
EP1435359A1 (en) * 2002-12-31 2004-07-07 Alembic Limited A process for the purification of roxithromycin
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
TW201038277A (en) * 2009-01-30 2010-11-01 Glaxosmithkline Zagreb Anti-inflammatory macrolide
EP2402355A1 (en) * 2010-07-01 2012-01-04 Novartis AG Crystalline anhydrous forms II and III of Tulathromycin
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN109942652B (zh) * 2017-12-21 2022-04-26 洛阳惠中兽药有限公司 一种莱柯霉素晶型ⅰ及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000576A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. Azithromycin dihydrate
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.

Also Published As

Publication number Publication date
SK16472001A3 (sk) 2003-02-04
OA11876A (en) 2006-03-27
YU76601A (sh) 2004-09-03
MA26735A1 (fr) 2004-12-20
HK1045521B (zh) 2005-12-09
BG106150A (bg) 2002-05-31
HN2000000056A (es) 2001-02-02
CZ20014120A3 (cs) 2003-01-15
PL353316A1 (en) 2003-11-17
EP1189912B1 (en) 2008-04-16
GT200000072A (es) 2001-11-08
MY133397A (en) 2007-11-30
NO20015598D0 (no) 2001-11-16
ES2302689T3 (es) 2008-08-01
HUP0201341A3 (en) 2003-03-28
WO2000069874A1 (en) 2000-11-23
ZA200109420B (en) 2002-11-15
DE60038610T2 (de) 2009-06-25
CA2372206A1 (en) 2000-11-23
DK1189912T3 (da) 2008-06-30
EA003417B1 (ru) 2003-04-24
ATE392427T1 (de) 2008-05-15
KR100474229B1 (ko) 2005-03-08
AR020030A1 (es) 2002-03-27
EP1189912A1 (en) 2002-03-27
EA200100984A1 (ru) 2002-06-27
DZ3043A1 (fr) 2004-03-27
CN1203084C (zh) 2005-05-25
NZ514765A (en) 2004-05-28
DE60038610D1 (de) 2008-05-29
NO20015598L (no) 2002-01-08
KR20020007415A (ko) 2002-01-26
CA2372206C (en) 2006-01-10
CN1351607A (zh) 2002-05-29
TNSN00103A1 (fr) 2005-11-10
NO320195B1 (no) 2005-11-14
HUP0201341A2 (en) 2002-08-28
HK1045521A1 (en) 2002-11-29
AU772283B2 (en) 2004-04-22
AP2001002325A0 (en) 2001-12-31
HRP20010849A2 (en) 2003-04-30
US6583274B1 (en) 2003-06-24
UA67842C2 (uk) 2004-07-15
AU3572900A (en) 2000-12-05
IS6127A (is) 2001-10-26
JP3897983B2 (ja) 2007-03-28
BR0011300A (pt) 2002-02-26
IL145946A0 (en) 2002-07-25
JP2002544283A (ja) 2002-12-24
MXPA01011914A (es) 2002-05-06
UY26144A1 (es) 2000-12-29
PT1189912E (pt) 2008-05-16
PE20010151A1 (es) 2001-02-08
IL145946A (en) 2007-06-17
TWI225066B (en) 2004-12-11

Similar Documents

Publication Publication Date Title
PA8506301A1 (es) Cristal de 4- carboxamino- 1,2,3,4,- tetrahidroquinolina 2-sustituida
BR0111667A (pt) Novos compostos
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
UY28342A1 (es) Nuevos compuestos
ES2178152T3 (es) Nuevas modificaciones de 2-amino-4-(4-fluorobenzilamino)-1-etoxicarbonilaminobenceno y procedimientos para la preparacion de dicho compuesto.
DOP2002000433A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso
UY28001A1 (es) Derivados de azol-pirimidina condensados
ES2178055T3 (es) Derivados aminicos substituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
ES2100151T3 (es) Nuevos derivados de benzopirano, procedimientos para su preparacion y su uso y composiciones que contienen los compuestos.
AR021981A1 (es) Composicion farmaceutica para una administracion por via oral destinada a evitar la desviacion de uso en detrimento de un tercero
HN2001000146A (es) Derivados de pirazol
PA8495001A1 (es) Nuevas formas cristalinas de un antibiotico macrolido.
HN2001000235A (es) Derivados puentes de piperazina
DK1051177T3 (da) Steroide 3-O-Sulfamatderivater som inhibitorer af östronsulfatase
PA8469101A1 (es) Ligandos azabiciclicos de receptores 5ht1
PA8577701A1 (es) Polipeptido t20 pegilado
BR0111669A (pt) Novos compostos
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
ES2174297T3 (es) Nuevos derivados de piranosidos.
AR005704A1 (es) Heteroariloxazolidinonas
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
UY26718A1 (es) Uso de compuestos de 1-amino-5-fenilpentano-3-ol y/o 1-amino-6-fenilhexano-3-ol para la preparación de un medicamento con efecto antagonista de n-metil-d-aspartato- (nmda)
AR009322A1 (es) Nuevas aril-piridazinas